Detalhe da pesquisa
1.
Progress against lung cancer, Denmark, 2008-2022.
Acta Oncol
; 63: 339-342, 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38745484
2.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
N Engl J Med
; 382(7): 597-609, 2020 02 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31825569
3.
European Respiratory Society guideline on various aspects of quality in lung cancer care.
Eur Respir J
; 61(2)2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36396145
4.
Who are the vulnerable lung cancer patients at risk for not receiving first-line curative or palliative treatment?
Acta Oncol
; 62(10): 1301-1308, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37656828
5.
Educational differences in healthcare use among survivors after breast, prostate, lung, and colon cancer - a SEQUEL cohort study.
BMC Health Serv Res
; 23(1): 674, 2023 Jun 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37349718
6.
An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership.
Cancer Control
; 29: 10732748221119354, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36269109
7.
Forecasting lung cancer incidence, mortality, and prevalence to year 2030.
BMC Cancer
; 21(1): 985, 2021 Sep 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34479490
8.
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.
Acta Oncol
; 60(2): 157-164, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33259244
9.
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(10): 1269-1282, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32861273
10.
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Breast Cancer Res
; 21(1): 39, 2019 03 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30867034
11.
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med
; 375(18): 1738-1748, 2016 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27717303
12.
Active Surveillance for Localized Prostate Cancer: Nationwide Observational Study.
J Urol
; 201(3): 520-527, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30240689
13.
Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene.
BMC Cancer
; 19(1): 573, 2019 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31196001
14.
Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.
Thorax
; 73(6): 530-537, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29511056
15.
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 168(1): 127-134, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29164421
16.
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 167(3): 659-669, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29058175
17.
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.
Breast Cancer Res Treat
; 172(2): 391-400, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30099635
18.
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.
Eur Respir J
; 52(6)2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30361252
19.
Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.
BMC Cancer
; 18(1): 1144, 2018 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-30458807
20.
Early death in Danish stage I lung cancer patients: a population-based case study.
Acta Oncol
; 57(11): 1561-1566, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30169986